Glück Conviction Score™ ⓘ
ZLAB
Zai Lab Ltd
Effektiv: Risiko-Ausstieg
Mittel
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
31,9
18 neu, 25 erhöht, 28,2M $ netto
Aktivist
43,0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bärisch | 10 % | 20.07 | -15.0 % vs SMA50 | |
| Kurs vs SMA200 | Bärisch | 15 % | 22.11 | -22.8 % vs SMA200 | |
| EMA20 vs EMA50 | Bärisch | 5 % | 17.92 | EMA50: 18.99 | |
| MACD-Histogramm | Bullisch | 10 % | 0.041 | Bullisch | |
| RSI(14) | Neutral | 10 % | 39.5 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 32.1 | Neutral | |
| ADX(14)+DI | Neutral | 10 % | 22.4 | +DI: 20.6 / −DI: 28.3 | |
| Z-Score(60) | Neutral | 5 % | -1.25 | In Range | |
| 52W-Position | Bärisch | 5 % | 2.9 % | Hoch 43.03 / Tief 16.30 | |
| Bollinger(20,2σ) | Neutral | 5 % | 29.6 % | Upper 19.95 / Mid 17.91 / Lower 15.86 | |
| LinReg-Slope(60) | Neutral | 10 % | -0.0477 | R²=0.15 / annualisiert -60.8 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-05-18 | Du Ying | Director, Officer, Chairperson & CEO | Open Market Sale | -50.000 | 19,00 | -949.765,00 | -242,1% | |
| 2026-05-15 | Du Ying | Director, Officer, Chairperson & CEO | Open Market Sale | -50.000 | 20,74 | -1.037.110,00 | -264,4% | |
| 2026-05-14 | Edmondson Frazor Titus III | Officer, Chief Legal Officer | Open Market Sale | -3.517 | 20,19 | -71.008,23 | -18,1% | |
| 2026-05-14 | Du Ying | Director, Officer, Chairperson & CEO | Open Market Sale | -50.000 | 20,09 | -1.004.575,00 | -256,1% | |
| 2026-05-13 | Du Ying | Director, Officer, Chairperson & CEO | Open Market Sale | -33.769 | 20,22 | -682.886,85 | -174,1% | |
| 2026-05-13 | Du Ying | Director, Officer, Chairperson & CEO | Open Market Sale | -16.231 | 19,44 | -315.582,58 | -80,5% | |
| 2026-04-06 | Du Ying | Director, Officer, Chairperson & CEO | Open Market Sale | -2.653 | 20,45 | -54.248,54 | -13,8% | |
| 2026-04-06 | Amado Rafael | Officer, See Remarks | Open Market Sale | -2.739 | 20,45 | -56.007,07 | -14,3% | |
| 2026-04-06 | Smiley Joshua L | Officer, See Remarks | Open Market Sale | -3.017 | 20,45 | -61.691,62 | -15,7% | |
| 2026-04-06 | Chen Yajing | Officer, Chief Financial Officer | Open Market Sale | -853 | 20,45 | -17.442,14 | -4,4% | |
| 2026-04-06 | Edmondson Frazor Titus III | Officer, Chief Legal Officer | Open Market Sale | -1.224 | 20,45 | -25.028,35 | -6,4% | |
| 2026-04-02 | Amado Rafael | Officer, See Remarks | Open Market Sale | -9.910 | 20,39 | -202.064,90 | -51,5% | |
| 2026-04-02 | Smiley Joshua L | Officer, See Remarks | Open Market Sale | -9.614 | 20,39 | -196.029,46 | -50,0% | |
| 2026-04-02 | Chen Yajing | Officer, Chief Financial Officer | Open Market Sale | -5.199 | 20,39 | -106.007,61 | -27,0% | |
| 2026-04-02 | Du Ying | Director, Officer, Chairperson & CEO | Open Market Sale | -5.576 | 20,39 | -113.694,64 | -29,0% | |
| 2026-04-02 | Edmondson Frazor Titus III | Officer, Chief Legal Officer | Open Market Sale | -4.194 | 20,39 | -85.515,66 | -21,8% | |
| 2026-03-17 | GAYNOR RICHARD | Director | Open Market Purchase | 1.731 | 18,91 | 32.733,21 | +8,3% | |
| 2026-03-13 | Amado Rafael | Officer, See Remarks | Open Market Sale | -2.957 | 18,63 | -55.083,00 | -14,0% | |
| 2026-03-13 | Edmondson Frazor Titus III | Officer, Chief Legal Officer | Open Market Sale | -1.281 | 18,63 | -23.862,47 | -6,1% | |
| 2026-03-13 | Smiley Joshua L | Officer, See Remarks | Open Market Sale | -1.966 | 18,63 | -36.622,65 | -9,3% | |
| 2026-03-13 | Chen Yajing | Officer, Chief Financial Officer | Open Market Sale | -1.703 | 18,63 | -31.723,48 | -8,1% | |
| 2026-03-11 | Du Ying | Director, Officer, Chairperson & CEO | Open Market Sale | -1.067 | 19,08 | -20.362,63 | -5,2% | |
| 2026-03-09 | Du Ying | Director, Officer, Chairperson & CEO | Open Market Sale | -50.000 | 19,03 | -951.465,00 | -242,6% | |
| 2026-03-06 | Du Ying | Director, Officer, Chairperson & CEO | Open Market Sale | -50.000 | 19,42 | -970.935,00 | -247,5% | |
| 2026-03-05 | Du Ying | Director, Officer, Chairperson & CEO | Open Market Sale | -50.000 | 19,22 | -961.055,00 | -245,0% | |
| 2026-03-05 | Edmondson Frazor Titus III | Officer, Chief Legal Officer | Open Market Sale | -15.569 | 19,06 | -296.745,14 | -75,7% | |
| 2026-03-04 | Du Ying | Director, Officer, Chairperson & CEO | Open Market Sale | -14.290 | 18,78 | -268.321,90 | -68,4% | |
| 2026-03-04 | Du Ying | Director, Officer, Chairperson & CEO | Open Market Sale | -35.710 | 19,32 | -689.831,50 | -175,9% | |
| 2026-03-03 | Amado Rafael | Officer, See Remarks | Open Market Sale | -10.000 | 17,38 | -173.800,00 | -44,3% | |
| 2025-12-31 | Amado Rafael | Officer, See Remarks | Open Market Sale | -10.787 | 17,43 | -188.038,98 | -47,9% | |
| 2025-12-16 | Edmondson Frazor Titus III | Officer, Chief Legal Officer | Open Market Sale | -8.651 | 17,14 | -148.278,14 | -37,8% | |
| 2025-11-21 | Edmondson Frazor Titus III | Officer, Chief Legal Officer | Open Market Sale | -14.328 | 19,78 | -283.407,84 | -72,3% | |
| 2025-11-03 | Chen Yajing | Officer, Chief Financial Officer | Open Market Sale | -240 | 26,83 | -6.439,44 | -1,6% | |
| 2025-10-02 | Chen Yajing | Officer, Chief Financial Officer | Open Market Sale | -456 | 34,25 | -15.616,63 | -4,0% | |
| 2025-09-10 | Smiley Joshua L | Officer, See Remarks | Open Market Purchase | 10.000 | 28,91 | 289.100,00 | +73,7% | |
| 2025-08-18 | Edmondson Frazor Titus III | Officer, Chief Legal Officer | Open Market Sale | -1.883 | 36,24 | -68.232,39 | -17,4% | |
| 2025-08-18 | Smiley Joshua L | Officer, See Remarks | Open Market Sale | -6.641 | 36,24 | -240.643,28 | -61,3% | |
| 2025-08-15 | Chen Yajing | Officer, Chief Financial Officer | Open Market Sale | -828 | 35,53 | -29.418,84 | -7,5% | |
| 2025-08-15 | Chen Yajing | Officer, Chief Financial Officer | Open Market Sale | -610 | 35,27 | -21.512,87 | -5,5% | |
| 2025-08-13 | Du Ying | Director, Officer, Chairperson & CEO | Open Market Sale | -46.387 | 35,47 | -1.645.286,59 | -419,4% | |
| 2025-08-12 | Du Ying | Director, Officer, Chairperson & CEO | Open Market Sale | -50.000 | 34,25 | -1.712.555,00 | -436,6% | |
| 2025-08-11 | Du Ying | Director, Officer, Chairperson & CEO | Open Market Sale | -50.000 | 34,64 | -1.731.815,00 | -441,5% | |
| 2025-08-08 | Du Ying | Director, Officer, Chairperson & CEO | Open Market Sale | -50.000 | 34,74 | -1.737.155,00 | -442,9% | |
| 2025-08-08 | Chen Yajing | Officer, Chief Financial Officer | Open Market Sale | -4.096 | 34,01 | -139.304,96 | -35,5% | |
| 2025-08-08 | Amado Rafael | Officer, See Remarks | Open Market Sale | -3.000 | 35,00 | -105.000,00 | -26,8% | |
| 2025-07-02 | Du Ying | Director, Officer, Chairperson & CEO | Open Market Sale | -7.072 | 35,23 | -249.146,56 | -63,5% | |
| 2025-06-30 | Du Ying | Director, Officer, Chairperson & CEO | Open Market Sale | -6.918 | 35,52 | -245.727,36 | -62,6% | |
| 2025-06-26 | Du Ying | Director, Officer, Chairperson & CEO | Open Market Sale | -23.669 | 36,13 | -855.208,31 | -218,0% | |
| 2025-06-26 | Edmondson Frazor Titus III | Officer, Chief Legal Officer | Open Market Sale | -5.877 | 36,13 | -212.347,76 | -54,1% | |
| 2025-06-26 | Chen Yajing | Officer, Chief Financial Officer | Open Market Sale | -2.675 | 36,13 | -96.653,10 | -24,6% | |
| 2025-06-20 | Lis William | Director | Open Market Sale | -13.814 | 35,67 | -492.745,38 | -125,6% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 6.574.032 | 6.959.032 | -385.000 | 123.657.542 | Reduziert | -5,5% | |
| RA CAPITAL MANAGEMENT, L.P. | 5.707.262 | 0 | 5.707.262 | 107.353.598 | Neu | +100,0% | |
| Frazier Life Sciences Management, L.P. | 1.902.320 | 1.902.320 | 0 | 35.782.639 | Unverändert | 0,0% | |
| CITADEL ADVISORS LLC | 1.721.832 | 1.749.546 | -27.714 | 32.387.659 | Reduziert | -1,6% | |
| Clearbridge Investments, LLC | 1.808.035 | 0 | 1.808.035 | 31.893.740 | Neu | +100,0% | |
| BAMCO INC /NY/ | 1.658.318 | 1.418.005 | 240.313 | 31.192.962 | Aufgestockt | +16,9% | |
| ADAR1 Capital Management, LLC | 1.425.367 | 1.246.520 | 178.847 | 26.811.153 | Aufgestockt | +14,3% | |
| FMR LLC | 1.262.391 | 1.440.406 | -178.015 | 23.745.575 | Reduziert | -12,4% | |
| BlackRock, Inc. | 865.146 | 635.213 | 229.933 | 16.273.397 | Aufgestockt | +36,2% | |
| Rock Springs Capital Management LP | 814.707 | 811.546 | 3.161 | 15.324.639 | Aufgestockt | +0,4% | |
| WELLINGTON MANAGEMENT GROUP LLP | 752.858 | 0 | 752.858 | 13.280.417 | Neu | +100,0% | |
| UBS Group AG | 504.191 | 1.782.252 | -1.278.061 | 9.483.833 | Reduziert | -71,7% | |
| JANE STREET GROUP, LLC | 466.926 | 577.562 | -110.636 | 8.782.877 | Reduziert | -19,2% | |
| B Group, Inc. | 450.646 | 400.000 | 50.646 | 8.476.651 | Aufgestockt | +12,7% | |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 393.167 | 299.844 | 93.323 | 7.018.031 | Aufgestockt | +31,1% | |
| BANK OF AMERICA CORP /DE/ | 388.769 | 0 | 388.769 | 6.857.886 | Neu | +100,0% | |
| NAN FUNG TRINITY (HK) Ltd | 346.466 | 269.975 | 76.491 | 6.517.025 | Aufgestockt | +28,3% | |
| TWO SIGMA INVESTMENTS, LP | 309.723 | 29.523 | 280.200 | 5.825.890 | Aufgestockt | +949,1% | |
| SUPERSTRING CAPITAL MANAGEMENT LP | 275.818 | 196.853 | 78.965 | 5.188.137 | Aufgestockt | +40,1% | |
| JPMORGAN CHASE & CO | 293.703 | 0 | 293.703 | 5.180.921 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 243.557 | 181.133 | 62.424 | 4.581.308 | Aufgestockt | +34,5% | |
| Aberdeen Group plc | 237.739 | 0 | 237.739 | 4.471.871 | Neu | +100,0% | |
| MARSHALL WACE, LLP | 231.802 | 0 | 231.802 | 4.088.987 | Neu | +100,0% | |
| Hennion & Walsh Asset Management, Inc. | 214.323 | 204.982 | 9.341 | 4.031.416 | Aufgestockt | +4,6% | |
| XY Capital Ltd | 202.304 | 0 | 202.304 | 3.568.643 | Neu | +100,0% | |
| Tidal Investments LLC | 183.691 | 0 | 183.691 | 3.455.228 | Neu | +100,0% | |
| NEXTBio Capital Management LP | 183.362 | 163.362 | 20.000 | 3.449.039 | Aufgestockt | +12,2% | |
| DIMENSIONAL FUND ADVISORS LP | 174.234 | 173.946 | 288 | 3.271.937 | Aufgestockt | +0,2% | |
| Campbell & CO Investment Adviser LLC | 170.117 | 0 | 170.117 | 3.000.864 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 145.448 | 148.195 | -2.747 | 2.735.877 | Reduziert | -1,9% | |
| Privium Fund Management B.V. | 132.189 | 132.189 | 0 | 2.486.475 | Unverändert | 0,0% | |
| STATE STREET CORP | 118.813 | 136.428 | -17.615 | 2.234.873 | Reduziert | -12,9% | |
| BNP Paribas Asset Management Holding S.A. | 116.560 | 65.814 | 50.746 | 2.192.494 | Aufgestockt | +77,1% | |
| GOLDMAN SACHS GROUP INC | 110.587 | 149.434 | -38.847 | 2.080.141 | Reduziert | -26,0% | |
| Qube Research & Technologies Ltd | 107.651 | 0 | 107.651 | 1.898.964 | Neu | +100,0% | |
| PRINCIPAL FINANCIAL GROUP INC | 101.782 | 0 | 101.782 | 1.795.434 | Neu | +100,0% | |
| Walleye Capital LLC | 94.778 | 373.399 | -278.621 | 1.782.774 | Reduziert | -74,6% | |
| MORGAN STANLEY | 94.397 | 289.705 | -195.308 | 1.775.616 | Reduziert | -67,4% | |
| ALPS ADVISORS INC | 90.848 | 92.107 | -1.259 | 1.708.851 | Reduziert | -1,4% | |
| RAYMOND JAMES FINANCIAL INC | 92.837 | 0 | 92.837 | 1.637.637 | Neu | +100,0% | |
| Seven Fleet Capital Management LP | 77.858 | 0 | 77.858 | 1.464.509 | Neu | +100,0% | |
| NEOS Investment Management LLC | 75.165 | 0 | 75.165 | 1.325.911 | Neu | +100,0% | |
| Legal & General Group Plc | 70.014 | 387.800 | -317.786 | 1.316.963 | Reduziert | -81,9% | |
| BAROMETER CAPITAL MANAGEMENT INC. | 66.500 | 0 | 66.500 | 1.250.865 | Neu | +100,0% | |
| DCF Advisers, LLC | 63.500 | 99.000 | -35.500 | 1.194.435 | Reduziert | -35,9% | |
| D. E. Shaw & Co., Inc. | 63.243 | 238.609 | -175.366 | 1.189.601 | Reduziert | -73,5% | |
| Long Corridor Asset Management Ltd | 65.800 | 0 | 65.800 | 1.160.712 | Neu | +100,0% | |
| Virtus Investment Advisers, LLC | 47.511 | 38.457 | 9.054 | 893.682 | Aufgestockt | +23,5% | |
| XTX Topco Ltd | 47.072 | 0 | 47.072 | 885.424 | Neu | +100,0% | |
| Schonfeld Strategic Advisors LLC | 40.005 | 0 | 40.005 | 705.687 | Neu | +100,0% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 6.574.032 | 6.959.032 | -5,5% | 123.657.542 | 23,68 |
| RA CAPITAL MANAGEMENT, L.P. | 5.707.262 | 0 | +100,0% | 107.353.598 | 20,56 |
| Frazier Life Sciences Management, L.P. | 1.902.320 | 1.902.320 | 0,0% | 35.782.639 | 6,85 |
| CITADEL ADVISORS LLC | 1.721.832 | 1.749.546 | -1,6% | 32.387.659 | 6,20 |
| BAMCO INC /NY/ | 1.658.318 | 1.418.005 | +16,9% | 31.192.962 | 5,97 |
| ADAR1 Capital Management, LLC | 1.425.367 | 1.246.520 | +14,3% | 26.811.153 | 5,13 |
| FMR LLC | 1.262.391 | 1.440.406 | -12,4% | 23.745.575 | 4,55 |
| BlackRock, Inc. | 865.146 | 635.213 | +36,2% | 16.273.397 | 3,12 |
| Rock Springs Capital Management LP | 814.707 | 811.546 | +0,4% | 15.324.639 | 2,93 |
| UBS Group AG | 504.191 | 1.782.252 | -71,7% | 9.483.833 | 1,82 |
| JANE STREET GROUP, LLC | 466.926 | 577.562 | -19,2% | 8.782.877 | 1,68 |
| B Group, Inc. | 450.646 | 400.000 | +12,7% | 8.476.651 | 1,62 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 393.167 | 299.844 | +31,1% | 7.018.031 | 1,34 |
| NAN FUNG TRINITY (HK) Ltd | 346.466 | 269.975 | +28,3% | 6.517.025 | 1,25 |
| TWO SIGMA INVESTMENTS, LP | 309.723 | 29.523 | +949,1% | 5.825.890 | 1,12 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 275.818 | 196.853 | +40,1% | 5.188.137 | 0,99 |
| AMERIPRISE FINANCIAL INC | 243.557 | 181.133 | +34,5% | 4.581.308 | 0,88 |
| Aberdeen Group plc | 237.739 | 0 | +100,0% | 4.471.871 | 0,86 |
| Hennion & Walsh Asset Management, Inc. | 214.323 | 204.982 | +4,6% | 4.031.416 | 0,77 |
| Tidal Investments LLC | 183.691 | 0 | +100,0% | 3.455.228 | 0,66 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 98 | 28,8 | 526 |
| 31.12.2025 | ✓ | 123 | 31,0 | 524 |
| 30.09.2025 | ✓ | 140 | 35,9 | 1.162 |
| 30.06.2025 | ✓ | 157 | 43,1 | 1.476 |
| 31.03.2025 | ✓ | 159 | 57,3 | 1.894 |
| 31.12.2024 | ✓ | 129 | 60,3 | 1.501 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| Walleye Capital LLC | 373.399 | 6.586.758 |
| XY Capital Ltd | 202.304 | 3.568.643 |
| AMERIPRISE FINANCIAL INC | 181.133 | 3.195.186 |
| Campbell & CO Investment Adviser LLC | 170.117 | 3.000.864 |
| NEXTBio Capital Management LP | 163.362 | 2.881.706 |
| Qube Research & Technologies Ltd | 107.651 | 1.898.964 |
| Hudson Bay Capital Management LP | 90.000 | 1.587.600 |
| Schonfeld Strategic Advisors LLC | 40.005 | 705.687 |
| DRW Securities, LLC | 30.862 | 544.405 |
| TWO SIGMA INVESTMENTS, LP | 29.523 | 520.786 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| RTW INVESTMENTS, LP | 6.959.032 | 4.667.660 | +203.7 % | 122.757.324 |
| UBS Group AG | 1.782.252 | 1.475.698 | +481.4 % | 31.438.925 |
| CITADEL ADVISORS LLC | 1.749.546 | 706.803 | +67.8 % | 30.861.992 |
| JANE STREET GROUP, LLC | 577.562 | 459.362 | +388.6 % | 10.188.194 |
| ADAR1 Capital Management, LLC | 1.246.520 | 377.740 | +43.5 % | 21.988.613 |
| JPMORGAN CHASE & CO | 293.703 | 284.296 | +3022.2 % | 5.180.921 |
| Frazier Life Sciences Management, L.P. | 1.902.320 | 275.000 | +16.9 % | 33.556.925 |
| BANK OF AMERICA CORP /DE/ | 388.769 | 246.395 | +173.1 % | 6.857.886 |
| D. E. Shaw & Co., Inc. | 238.609 | 204.319 | +595.9 % | 4.209.063 |
| MARSHALL WACE, LLP | 231.802 | 170.400 | +277.5 % | 4.088.987 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| FMR LLC | 1.440.406 | -3.261.305 | -69.4 % | 25.408.762 |
| Clearbridge Investments, LLC | 1.808.035 | -1.711.302 | -48.6 % | 31.893.740 |
| WELLINGTON MANAGEMENT GROUP LLP | 752.858 | -965.597 | -56.2 % | 13.280.417 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 602.954 | -345.717 | -36.4 % | 10.637 |
| LMR Partners LLP | 10.320 | -122.348 | -92.2 % | 182.045 |
| ENVESTNET ASSET MANAGEMENT INC | 151.318 | -100.712 | -40.0 % | 2.669.246 |
| RAYMOND JAMES FINANCIAL INC | 92.837 | -91.929 | -49.8 % | 1.637.637 |
| WELLS FARGO & COMPANY/MN | 93.140 | -81.992 | -46.8 % | 1.642.990 |
| IvyRock Asset Management (HK) Ltd | 14.979 | -79.900 | -84.2 % | 264.230 |
| LPL Financial LLC | 31.114 | -53.996 | -63.4 % | 548.851 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 12.06.2026 | TCG Crossover Fund III, L.P. | Passiv (13G) | 2,60 % | 29.565.420 | Neu | |
| 12.06.2026 | TCG Crossover GP II, LLC | Passiv (13G) | 2,60 % | 29.565.330 | Neu | |
| 12.06.2026 | Chen Yu | Passiv (13G) | 5,30 % | 59.130.750 | Neu | |
| 12.06.2026 | TCG Crossover GP III, LLC | Passiv (13G) | 2,60 % | 29.565.420 | Neu | |
| 12.06.2026 | TCG Crossover Fund II, L.P. | Passiv (13G) | 2,60 % | 29.565.330 | Neu | |
| 07.04.2026 | RA Capital Healthcare Fund, L.P. | Passiv (13G) | 5,20 % | 57.435.330 | Neu | |
| 07.04.2026 | RA Capital Management, L.P. | Passiv (13G) | 5,20 % | 57.435.330 | Neu | |
| 07.04.2026 | Rajeev Shah | Passiv (13G) | 5,20 % | 57.435.330 | Neu | |
| 07.04.2026 | Peter Kolchinsky | Passiv (13G) | 5,20 % | 57.435.330 | Neu | |
| 17.02.2026 | RTW Investments, LP | Passiv (13G) | 6,30 % | 69.590.320 | +4,20 pp | |
| 17.02.2026 | Roderick Wong | Passiv (13G) | 6,30 % | 69.590.320 | +4,20 pp | |
| 13.02.2026 | Qiming Venture Partners IV, L.P. | Passiv (13G/A) | 4,20 % | 47.387.408 | -1,59 pp | |
| 13.02.2026 | Qiming Corporate GP IV, Ltd. | Passiv (13G/A) | 4,40 % | 48.883.643 | -1,57 pp | |
| 13.02.2026 | Qiming GP IV, L.P. | Passiv (13G/A) | 4,20 % | 47.387.408 | Neu | |
| 13.02.2026 | Qiming Managing Directors Fund IV, L.P. | Passiv (13G/A) | 0,10 % | 1.496.235 | Neu | |
| 13.02.2026 | QM11 Limited | Passiv (13G/A) | 4,40 % | 48.883.643 | -1,57 pp | |
| 13.02.2026 | Capital World Investors | Passiv (13G/A) | 0,20 % | 1.723.600 | Neu | |
| 10.02.2026 | Wellington Group Holdings LLP | Passiv (13G/A) | 4,30 % | 48.112.590 | -1,70 pp | |
| 10.02.2026 | Wellington Investment Advisors Holdings LLP | Passiv (13G/A) | 4,30 % | 48.112.590 | -1,70 pp | |
| 10.02.2026 | Wellington Management Group LLP | Passiv (13G/A) | 4,30 % | 48.112.590 | -1,70 pp | |
| 05.02.2026 | FMR LLC | Passiv (13G/A) | 3,90 % | 43.535.993 | -2,50 pp | |
| 05.02.2026 | Abigail P. Johnson | Passiv (13G/A) | 3,90 % | 43.535.993 | -2,50 pp | |
| 14.11.2025 | RTW Investments, LP | Passiv (13G/A) | 2,10 % | 22.913.720 | -3,00 pp | |
| 14.11.2025 | Roderick Wong | Passiv (13G/A) | 2,10 % | 22.913.720 | -3,00 pp | |
| 12.11.2025 | Wellington Group Holdings LLP | Passiv (13G) | 6,00 % | 67.415.323 | +1,50 pp | |
| 12.11.2025 | Wellington Investment Advisors Holdings LLP | Passiv (13G) | 6,00 % | 67.415.323 | +1,50 pp | |
| 12.11.2025 | Wellington Management Company LLP | Passiv (13G) | 5,40 % | 67.415.323 | -0,30 pp | |
| 12.11.2025 | Wellington Management Group LLP | Passiv (13G) | 6,00 % | 67.415.323 | +1,50 pp | |
| 05.11.2025 | FMR LLC | Passiv (13G/A) | 6,40 % | 71.683.793 | -2,10 pp | |
| 05.11.2025 | Abigail P. Johnson | Passiv (13G/A) | 6,40 % | 71.683.793 | -2,10 pp | |
| 14.08.2025 | RTW Investments, LP | Passiv (13G) | 5,10 % | 55.368.760 | Neu | |
| 14.08.2025 | Roderick Wong | Passiv (13G) | 5,10 % | 55.368.760 | Neu | |
| 12.08.2025 | Qiming GP IV, L.P | Passiv (13G/A) | 5,79 % | 64.299.112 | Neu | |
| 12.08.2025 | Qiming Corporate GP IV, Ltd. | Passiv (13G/A) | 5,97 % | 66.329.320 | Neu | |
| 12.08.2025 | QM11 Limited | Passiv (13G/A) | 5,97 % | 66.329.320 | Neu | |
| 12.08.2025 | Qiming Venture Partners IV, L.P. | Passiv (13G/A) | 5,79 % | 64.299.112 | Neu | |
| 12.08.2025 | Qiming Managing Directors Fund IV, L.P | Passiv (13G/A) | 0,18 % | 2.030.208 | Neu | |
| 12.08.2025 | Wellington Group Holdings LLP | Passiv (13G/A) | 4,50 % | 50.084.792 | -1,90 pp | |
| 12.08.2025 | Wellington Management Group LLP | Passiv (13G/A) | 4,50 % | 50.084.792 | -1,90 pp | |
| 12.08.2025 | Wellington Investment Advisors Holdings LLP | Passiv (13G/A) | 4,50 % | 50.084.792 | -1,90 pp |
Stammdaten
Zai Lab Limited entwickelt und vermarktet Therapien zur Behandlung von Onkologie, Autoimmunerkrankungen, Infektionskrankheiten und Neurowissenschaften hauptsächlich in Festlandchina und Hongkong. Die kommerziellen Produkte des Unternehmens umfassen Zejula, einen täglich einzunehmenden Poly-Polymerase-1/2-Inhibitor mit kleinem Molekül; Optune, ein Gerät zur Abgabe von Tumor-Behandlungsfeldern; NUZYRA zur Behandlung akuter bakterieller Haut- und Hautstrukturinfektionen und von in der Gemeinschaft erworbener bakterieller Lungenentzündung; und Qinlock zur Behandlung von gastrointestinalen Stromatumoren. Das Unternehmen entwickelt auch Odronextamab zur Behandlung von Follikulärem Lymphom, diffusem großzelligem B-Zell-Lymphom und anderen B-Zell-Lymphomen; Repotrectinib, einen Tyrosinkinase-Inhibitor (TKI) zur Ansteuerung von ROS1 und TRK A/B/C bei TKI-naïven oder vorbehandelten Krebspatienten; Margetuximab zur Behandlung von Brust- und gastroösophagealem Krebs; Adagrasib zur Behandlung von KRAS-G12C-mutiertem nicht-kleinzelligem Lungenkarzinom, Darmkrebs, Bauchspeicheldrüsenkrebs und anderen soliden Tumoren; und Bemarituzumab zur Behandlung von Magen- und gastroösophagealem Übergangskrebs. Darüber hinaus entwickelt das Unternehmen CLN-081 zur Behandlung von Patienten mit EGFR-Exon-20-Insertions-NSCLC; Elzovantinib, einen oral bioverfügbaren Mehrfach-Kinase-Inhibitor; Tebotelimab, einen tetravalenten IgG4-monoklonalen Antikörper; Retifanlimab, das die Wechselwirkungen zwischen PD-1 und seinen Liganden hemmt; ZL-2309, einen oral aktiven, selektiven und ATP-konkurrierenden Zellzyklus-7-(CDC7)-Kinase-Inhibitor; ZL-1201, einen humanisierten IgG4-monoklonalen Antikörper; Efgartigimod zur Verringerung von krankheitsverursachenden Immunglobulin-G-Antikörpern; ZL-1102, einen humanen Nanobody, der auf Interleukin-17A abzielt; KarXT zur Behandlung von psychiatrischen und neurologischen Erkrankungen; ZL-2313, einen experimentellen Inhibitor für dreifach-mutantes EGFR; ZL-2314, einen experimentellen Inhibitor für doppelt-mutantes EGFR; und Sulbactam/Durlobactam zur Behandlung schwerwiegender Infektionen, die durch Acinetobacter verursacht werden. Zai Lab Limited wurde 2013 gegründet und hat seinen Hauptsitz in Shanghai, China.
Unternehmen & Branche
| Name | Zai Lab Ltd |
|---|---|
| Ticker | ZLAB |
| CIK | 0001704292 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 98887Q104 |
|---|---|
| ISIN | US98887Q1040 |
| Typ | ADR |
| Marktkapitalisierung | 19,52 Mrd. USD |
| Beta | 0,85 |
Bewertung
| KBV (P/B) | 27,28 vs. 43,49 (2021) ▼ |
|---|---|
| KUV (P/S) | 42,41 vs. 415,91 (2021) ▼ |
| FCF-Rendite | -0,8 % vs. -0,9 % (2021) ▲ |
Qualität & Bilanz
| Bruttomarge | 58,6 % vs. 63,8 % (2021) ▼ |
|---|---|
| Operative Marge | -49,9 % vs. -485,1 % (2021) ▲ |
| Nettomarge | -38,1 % vs. -488,2 % (2021) ▲ |
| ROIC | -18,7 % vs. -50,5 % (2021) ▲ |
| Zinsdeckungsgrad | -44,0 |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KBV (P/B) | 43,49 | 28,19 | 33,38 | 33,57 | 27,28 | |
| KUV (P/S) | 415,91 | 137,08 | 99,62 | 70,74 | 42,41 | |
| FCF-Rendite | -0,9 % | -1,3 % | -0,8 % | -0,8 % | -0,8 % | |
| Qualität & Bilanz | ||||||
| Bruttomarge | 63,8 % | 65,6 % | 64,1 % | 63,1 % | 58,6 % | |
| Operative Marge | -485,1 % | -188,0 % | -137,4 % | -70,7 % | -49,9 % | |
| Nettomarge | -488,2 % | -206,1 % | -125,5 % | -64,4 % | -38,1 % | |
| ROIC | -50,5 % | -41,6 % | -41,2 % | -25,9 % | -18,7 % | |
| Zinsdeckungsgrad | – | – | – | -125,2 | -44,0 | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | 99.611.000 | -51.016.000 | -0,05 | 1.095.737.000 | 661.981.000 |
| 2025-12-31 | 10-K | 460.156.000 | -175.537.000 | -0,16 | 1.172.384.000 | 715.500.000 |
| 2025-09-30 | 10-Q | 116.095.000 | -35.963.000 | -0,03 | 1.158.940.000 | 759.945.000 |
| 2025-06-30 | 10-Q | 109.977.000 | -40.727.000 | -0,04 | 1.164.101.000 | 791.735.000 |
| 2025-03-31 | 10-Q | 106.487.000 | -48.438.000 | -0,04 | 1.173.330.000 | 810.753.000 |
| 2024-12-31 | 10-K | 398.988.000 | -257.103.000 | -0,26 | 1.185.753.000 | 840.898.000 |
| 2024-09-30 | 10-Q | 102.265.000 | -41.671.000 | -0,04 | 985.346.000 | 667.669.000 |
| 2024-06-30 | 10-Q | 100.504.000 | -80.277.000 | -0,08 | 987.368.000 | 704.179.000 |
| 2024-03-31 | 10-Q | 87.149.000 | -53.471.000 | -0,05 | 988.437.000 | 762.169.000 |
| 2023-12-31 | 10-K | 266.719.000 | -334.620.000 | -0,35 | 1.036.295.000 | 796.118.000 |
| 2023-09-30 | 10-Q | 69.228.000 | -69.152.000 | -0,07 | 1.043.694.000 | 880.979.000 |
| 2023-06-30 | 10-Q | 68.864.000 | -120.895.000 | -0,13 | 1.106.373.000 | 932.314.000 |
| 2023-03-31 | 10-Q | 62.797.000 | -49.144.000 | -0,05 | 1.170.074.000 | 1.001.242.000 |
| 2022-12-31 | 10-K | 215.040.000 | -443.286.000 | -0,46 | 1.220.140.000 | 1.045.595.000 |
| 2022-09-30 | 10-Q | 57.540.000 | -161.190.000 | -0,17 | 1.298.514.000 | 1.105.869.000 |
| 2022-06-30 | 10-Q | 48.176.000 | -137.933.000 | -0,14 | 1.418.777.000 | 1.212.165.000 |
| 2022-03-31 | 10-Q | 46.724.000 | -82.394.000 | -0,09 | 1.500.915.000 | 1.308.008.000 |
| 2021-12-31 | 10-K | 144.312.000 | -704.471.000 | -0,76 | 1.609.956.000 | 1.379.956.000 |
| 2021-09-30 | 10-Q | 43.103.000 | -96.412.000 | -0,10 | 1.728.079.000 | 1.587.930.000 |
| 2021-06-30 | 10-Q | 36.935.000 | -163.324.000 | -0,18 | 1.895.215.000 | 1.671.698.000 |
Umsatz nach Segmenten & Regionen ⓘ
Geschäftssegmente
| Segment | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| Zejula | 189,0 Mio. | 187,1 Mio. | 168,8 Mio. | 145,2 Mio. | 93,6 Mio. | 41,3 % | +1,0% | |
| Vyvgart Vyvgart Hytrulo | 94,2 Mio. | 93,6 Mio. | 10,0 Mio. | – | – | 20,6 % | +0,6% | |
| Nuzyra | 60,8 Mio. | 43,2 Mio. | 21,7 Mio. | 5,2 Mio. | 3.000 | 13,3 % | +40,8% | |
| Optune | 48,3 Mio. | 40,5 Mio. | 47,0 Mio. | 47,3 Mio. | 38,9 Mio. | 10,6 % | +19,4% | |
| Qinlock | 35,6 Mio. | 28,8 Mio. | 19,2 Mio. | 15,0 Mio. | 11,6 Mio. | 7,8 % | +23,5% | |
| XACDURO | 22,9 Mio. | 3,3 Mio. | – | – | – | 5,0 % | +593,3% | |
| AUGTYRO | 5,5 Mio. | 1,1 Mio. | – | – | – | 1,2 % | +409,0% | |
| Product And Service Other | 717.000 | – | – | – | – | 0,2 % | Neu |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 07.05.2026 | 99,6 Mio. USD | -0,05 |
| Q3 2025 | 30.09.2025 | 06.11.2025 | 116,1 Mio. USD | -0,03 |
| Q2 2025 | 30.06.2025 | 06.11.2025 | 110,0 Mio. USD | -0,04 |
| Q1 2025 | 31.03.2025 | 07.05.2026 | 106,5 Mio. USD | -0,04 |
| Q3 2024 | 30.09.2024 | 06.11.2025 | 102,3 Mio. USD | -0,04 |
| Q2 2024 | 30.06.2024 | 06.11.2025 | 100,5 Mio. USD | -0,08 |
| Q1 2024 | 31.03.2024 | 06.11.2025 | 87,1 Mio. USD | -0,05 |
| Q3 2023 | 30.09.2023 | 12.11.2024 | 69,2 Mio. USD | -0,07 |
| Q2 2023 | 30.06.2023 | 12.11.2024 | 68,9 Mio. USD | -0,13 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 07.05.2026 | 10-Q | – | – | SEC » |
| 26.02.2026 | 10-K | 31.12.2025 | 57 Tage | SEC » |
| 06.11.2025 | 10-Q | 30.09.2025 | 37 Tage | SEC » |
| 07.08.2025 | 10-Q | 30.06.2025 | 38 Tage | SEC » |
| 08.05.2025 | 10-Q | 31.03.2025 | 38 Tage | SEC » |
| 27.02.2025 | 10-K | 31.12.2024 | 58 Tage | SEC » |
| 12.11.2024 | 10-Q | 30.09.2024 | 43 Tage | SEC » |
| 06.08.2024 | 10-Q | 30.06.2024 | 37 Tage | SEC » |
| 08.05.2024 | 10-Q | 31.03.2024 | 38 Tage | SEC » |
| 27.02.2024 | 10-K | 31.12.2023 | 58 Tage | SEC » |
| 22.12.2023 | 10-K/A | 31.12.2022 | 356 Tage | SEC » |
| 07.11.2023 | 10-Q | 30.09.2023 | 38 Tage | SEC » |
| 07.08.2023 | 10-Q | 30.06.2023 | 38 Tage | SEC » |
| 09.05.2023 | 10-Q | 31.03.2023 | 39 Tage | SEC » |
| 01.03.2023 | 10-K | 31.12.2022 | 60 Tage | SEC » |
| 09.11.2022 | 10-Q | 30.09.2022 | 40 Tage | SEC » |
| 09.08.2022 | 10-Q | 30.06.2022 | 40 Tage | SEC » |
| 10.05.2022 | 10-Q | 31.03.2022 | 40 Tage | SEC » |
| 01.03.2022 | 10-K | 31.12.2021 | 60 Tage | SEC » |
| 09.11.2021 | 10-Q | 30.09.2021 | 40 Tage | SEC » |
| 09.08.2021 | 10-Q | 30.06.2021 | 40 Tage | SEC » |
| 10.05.2021 | 10-Q | 31.03.2021 | 40 Tage | SEC » |
| 01.03.2021 | 10-K | 31.12.2020 | 60 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (21.05.2026)
HOCH Abgang Schlüsselpersonen (21.05.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 21.05.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 18.06.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 11.06.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 06.07.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-14 | 4.115 | 20,47 | 84.234 |
| 2026-05-06 | 1.785 | 20,98 | 37.449 |
| 2026-05-05 | 120 | 21,22 | 2.546 |
| 2026-05-04 | 1.106 | 21,54 | 23.823 |
| 2026-04-30 | 99 | 20,75 | 2.054 |
| 2026-04-29 | 1.402 | 22,14 | 31.040 |
| 2026-04-28 | 302 | 21,88 | 6.608 |
| 2026-04-27 | 3.341 | 22,77 | 76.075 |
| 2026-04-22 | 1.951 | 24,44 | 47.682 |
| 2026-04-20 | 1.643 | 24,19 | 39.744 |
| 2026-04-17 | 182.717 | 23,50 | 4.293.850 |
| 2026-04-16 | 123.176 | 23,25 | 2.863.842 |
| 2026-04-15 | 74.265 | 21,96 | 1.630.859 |
| 2026-04-14 | 18.418 | 21,34 | 393.040 |
| 2026-04-13 | 7.757 | 20,68 | 160.415 |
| 2026-04-10 | 92.188 | 20,74 | 1.911.979 |
| 2026-04-09 | 17.759 | 21,39 | 379.865 |
| 2026-04-08 | 52.750 | 21,00 | 1.107.750 |
| 2026-04-07 | 54.465 | 20,50 | 1.116.533 |
| 2026-04-02 | 1.073 | 20,34 | 21.825 |
| 2026-04-01 | 13.938 | 18,81 | 262.174 |
| 2026-03-31 | 14.250 | 17,85 | 254.363 |
| 2026-03-30 | 5.052 | 18,00 | 90.936 |
| 2026-03-27 | 60.611 | 17,51 | 1.061.299 |
| 2026-03-26 | 12.433 | 18,29 | 227.400 |
| 2026-03-25 | 110.350 | 17,47 | 1.927.814 |
| 2026-03-23 | 43.901 | 18,09 | 794.169 |
| 2026-03-20 | 168.321 | 18,61 | 3.132.454 |
| 2026-03-18 | 42.103 | 19,02 | 800.799 |
| 2026-03-17 | 84.237 | 19,06 | 1.605.557 |
| 2026-03-16 | 22.732 | 18,37 | 417.587 |
| 2026-03-13 | 4.755 | 18,87 | 89.727 |
| 2026-03-06 | 2.985 | 19,30 | 57.611 |
| 2026-03-05 | 1.174 | 19,27 | 22.623 |
| 2026-03-04 | 47.095 | 17,72 | 834.523 |
| 2026-03-03 | 42.405 | 18,42 | 781.100 |
| 2026-03-02 | 1.459 | 19,22 | 28.042 |
| 2026-02-27 | 2.997 | 19,69 | 59.011 |
| 2026-02-25 | 70 | 19,37 | 1.356 |
| 2026-02-23 | 21.309 | 20,04 | 427.032 |
| 2026-02-20 | 637 | 20,08 | 12.791 |
| 2026-02-19 | 48 | 20,18 | 969 |
| 2026-02-18 | 3.249 | 20,04 | 65.110 |
| 2026-02-17 | 521 | 20,03 | 10.436 |
| 2026-02-12 | 709 | 19,03 | 13.492 |
| 2026-02-06 | 4.501 | 16,98 | 76.427 |
| 2026-02-05 | 8.406 | 17,00 | 142.902 |
| 2026-02-04 | 117 | 16,43 | 1.922 |
| 2026-01-23 | 9 | 18,37 | 165 |
| 2026-01-22 | 70 | 18,84 | 1.319 |
| 2026-01-06 | 15.500 | 18,09 | 280.395 |
| 2026-01-05 | 12.035 | 17,33 | 208.567 |
| 2025-12-22 | 1.406 | 18,04 | 25.364 |
| 2025-12-19 | 70 | 17,18 | 1.203 |